Abstract
Because the tumor is contained within a foci of lung parenchyma, the foundation of treatment of stage I non-small cell lung cancer is complete resection of the neoplasm and achieving microscopically negative margins. The choice of operation is crucial. Because of its more favorable local recurrence and 5-year survival rates, lobectomy with mediastinal lymphadenectomy is the gold standard for treating patients with clinical stage I non-small cell lung cancer who have sufficient cardiopulmonary reserve, including older patients.
Original language | English (US) |
---|---|
Pages (from-to) | 203-215 |
Number of pages | 13 |
Journal | Thoracic surgery clinics |
Volume | 17 |
Issue number | 2 |
DOIs | |
State | Published - May 2007 |